32 related articles for article (PubMed ID: 11179833)
1. Mutation analysis underlying the downregulation of the thyroid hormone receptor β1 gene in the Chinese breast cancer population.
Ling Y; Ling X; Fan L; Wang Y; Li Q
Onco Targets Ther; 2015; 8():2967-72. PubMed ID: 26527882
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 and MDM2 as independent blood-based biomarkers of head and neck cancer.
Bhowmik A; Das S; Bhattacharjee A; Choudhury B; Naiding M; Ghosh SK; Choudhury Y
Tumour Biol; 2016 Oct; ():. PubMed ID: 27714671
[TBL] [Abstract][Full Text] [Related]
3. TP53 in bone and soft tissue sarcomas.
Thoenen E; Curl A; Iwakuma T
Pharmacol Ther; 2019 Oct; 202():149-164. PubMed ID: 31276706
[TBL] [Abstract][Full Text] [Related]
4. The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
Li H; Liu Q; Wang Z; Fang R; Shen Y; Cai X; Gao Y; Li Y; Zhang X; Ye L
J Biol Chem; 2015 Sep; 290(37):22649-61. PubMed ID: 26229107
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of vorinostat in a patient with leiomyosarcoma.
Lee J; McGuire C
Clin Med Insights Oncol; 2012; 6():101-5. PubMed ID: 22408374
[TBL] [Abstract][Full Text] [Related]
6. Targeting the p53 Pathway in Ewing Sarcoma.
Neilsen PM; Pishas KI; Callen DF; Thomas DM
Sarcoma; 2011; 2011():746939. PubMed ID: 21197471
[TBL] [Abstract][Full Text] [Related]
7. The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma.
Zhang KJ; Wang DS; Zhang SY; Jiao XL; Li CW; Wang XS; Yu QC; Cui HN
J Exp Clin Cancer Res; 2010 Jul; 29(1):88. PubMed ID: 20594328
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of uterine leiomyosarcomas: involvement of defect in LMP2 expression.
Hayashi T; Shimamura Y; Saegusa T; Horiuchi A; Kobayashi Y; Hiraoka N; Kanai Y; Aburatani H; Sano K; Konishi I
Gene Regul Syst Bio; 2008 Jul; 2():297-305. PubMed ID: 19787091
[TBL] [Abstract][Full Text] [Related]
9. p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours.
Dimitriadi M; Poulogiannis G; Liu L; Bäcklund LM; Pearson DM; Ichimura K; Collins VP
Br J Cancer; 2008 Oct; 99(7):1144-52. PubMed ID: 18781178
[TBL] [Abstract][Full Text] [Related]
10. The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck.
Alhopuro P; Ylisaukko-Oja SK; Koskinen WJ; Bono P; Arola J; Järvinen HJ; Mecklin JP; Atula T; Kontio R; Mäkitie AA; Suominen S; Leivo I; Vahteristo P; Aaltonen LM; Aaltonen LA
J Med Genet; 2005 Sep; 42(9):694-8. PubMed ID: 16141004
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
[TBL] [Abstract][Full Text] [Related]
12. Extrapleural solitary fibrous tumor: clinicopathologic study of 17 cases and molecular analysis of the p53 pathway.
Morimitsu Y; Nakajima M; Hisaoka M; Hashimoto H
APMIS; 2000 Sep; 108(9):617-25. PubMed ID: 11110050
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutation and MDM2 overexpression in a case of primary malignant fibrous histiocytoma of the jejunum.
Jiao YF; Nakamura S; Sugai T; Habano W; Uesugi N; Oikawa M; Sato T
APMIS; 2002 Feb; 110(2):165-71. PubMed ID: 12064872
[TBL] [Abstract][Full Text] [Related]
14. Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction.
Miyajima K; Tamiya S; Oda Y; Adachi T; Konomoto T; Toyoshiba H; Masuda K; Tsuneyoshi M
Cancer Lett; 2001 Mar; 164(2):177-88. PubMed ID: 11179833
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas.
Patterson H; Gill S; Fisher C; Law MG; Jayatilake H; Fletcher CD; Thomas M; Grimer R; Gusterson BA; Cooper CS
Br J Cancer; 1994 Jun; 69(6):1052-8. PubMed ID: 8198970
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
